nodes	percent_of_prediction	percent_of_DWPC	metapath
Mianserin—Azatadine—Loratadine—atopic dermatitis	0.189	0.363	CrCrCtD
Mianserin—Diphenylpyraline—Dimenhydrinate—atopic dermatitis	0.0789	0.152	CrCrCtD
Mianserin—HRH1—Dimenhydrinate—atopic dermatitis	0.071	0.232	CbGbCtD
Mianserin—Cyclizine—Dimenhydrinate—atopic dermatitis	0.0707	0.136	CrCrCtD
Mianserin—Amitriptyline—Diphenhydramine—atopic dermatitis	0.0403	0.0776	CrCrCtD
Mianserin—Diphenylpyraline—Diphenhydramine—atopic dermatitis	0.0374	0.0721	CrCrCtD
Mianserin—Trimipramine—Diphenhydramine—atopic dermatitis	0.0366	0.0704	CrCrCtD
Mianserin—HRH1—Diphenhydramine—atopic dermatitis	0.0347	0.113	CbGbCtD
Mianserin—HRH1—Loratadine—atopic dermatitis	0.0347	0.113	CbGbCtD
Mianserin—Imipramine—Diphenhydramine—atopic dermatitis	0.0335	0.0646	CrCrCtD
Mianserin—Cyclizine—Diphenhydramine—atopic dermatitis	0.0335	0.0646	CrCrCtD
Mianserin—CYP2B6—Diphenhydramine—atopic dermatitis	0.0286	0.0935	CbGbCtD
Mianserin—CYP3A4—Pimecrolimus—atopic dermatitis	0.0202	0.066	CbGbCtD
Mianserin—CYP1A2—Diphenhydramine—atopic dermatitis	0.0168	0.0548	CbGbCtD
Mianserin—CYP2D6—Loratadine—atopic dermatitis	0.0138	0.0451	CbGbCtD
Mianserin—CYP2D6—Diphenhydramine—atopic dermatitis	0.0138	0.0451	CbGbCtD
Mianserin—CYP3A4—Tacrolimus—atopic dermatitis	0.012	0.0392	CbGbCtD
Mianserin—CYP2B6—Dexamethasone—atopic dermatitis	0.00991	0.0323	CbGbCtD
Mianserin—CYP3A4—Loratadine—atopic dermatitis	0.0088	0.0287	CbGbCtD
Mianserin—CYP3A4—Methylprednisolone—atopic dermatitis	0.00805	0.0263	CbGbCtD
Mianserin—CYP3A4—Triamcinolone—atopic dermatitis	0.0061	0.0199	CbGbCtD
Mianserin—CYP3A4—Betamethasone—atopic dermatitis	0.00523	0.0171	CbGbCtD
Mianserin—CYP3A4—Prednisolone—atopic dermatitis	0.00516	0.0168	CbGbCtD
Mianserin—CYP3A4—Hydrocortisone—atopic dermatitis	0.00489	0.016	CbGbCtD
Mianserin—CYP3A4—Prednisone—atopic dermatitis	0.00488	0.0159	CbGbCtD
Mianserin—CYP2D6—Dexamethasone—atopic dermatitis	0.00479	0.0156	CbGbCtD
Mianserin—CYP3A4—Dexamethasone—atopic dermatitis	0.00304	0.00993	CbGbCtD
Mianserin—Gastrointestinal disorder—Fluocinolone Acetonide—atopic dermatitis	0.000265	0.00248	CcSEcCtD
Mianserin—Hyperkinesia—Prednisone—atopic dermatitis	0.000265	0.00248	CcSEcCtD
Mianserin—Cardiac arrest—Methylprednisolone—atopic dermatitis	0.000265	0.00248	CcSEcCtD
Mianserin—Anaemia—Tacrolimus—atopic dermatitis	0.000265	0.00248	CcSEcCtD
Mianserin—Paraesthesia—Mometasone—atopic dermatitis	0.000264	0.00247	CcSEcCtD
Mianserin—Agitation—Tacrolimus—atopic dermatitis	0.000263	0.00246	CcSEcCtD
Mianserin—Cardiac failure—Dexamethasone—atopic dermatitis	0.00026	0.00243	CcSEcCtD
Mianserin—Cardiac failure—Betamethasone—atopic dermatitis	0.00026	0.00243	CcSEcCtD
Mianserin—Lethargy—Dexamethasone—atopic dermatitis	0.000258	0.00242	CcSEcCtD
Mianserin—Lethargy—Betamethasone—atopic dermatitis	0.000258	0.00242	CcSEcCtD
Mianserin—Vertigo—Tacrolimus—atopic dermatitis	0.000257	0.00241	CcSEcCtD
Mianserin—Syncope—Tacrolimus—atopic dermatitis	0.000257	0.0024	CcSEcCtD
Mianserin—Leukopenia—Tacrolimus—atopic dermatitis	0.000256	0.0024	CcSEcCtD
Mianserin—Fatigue—Mometasone—atopic dermatitis	0.000253	0.00237	CcSEcCtD
Mianserin—Breast disorder—Methylprednisolone—atopic dermatitis	0.000252	0.00236	CcSEcCtD
Mianserin—Loss of consciousness—Tacrolimus—atopic dermatitis	0.000252	0.00235	CcSEcCtD
Mianserin—Convulsion—Tacrolimus—atopic dermatitis	0.000248	0.00232	CcSEcCtD
Mianserin—Hypertension—Tacrolimus—atopic dermatitis	0.000247	0.00231	CcSEcCtD
Mianserin—Asthenia—Loratadine—atopic dermatitis	0.000245	0.0023	CcSEcCtD
Mianserin—Myalgia—Tacrolimus—atopic dermatitis	0.000244	0.00228	CcSEcCtD
Mianserin—Arthralgia—Tacrolimus—atopic dermatitis	0.000244	0.00228	CcSEcCtD
Mianserin—Unspecified disorder of skin and subcutaneous tissue—Tacrolimus—atopic dermatitis	0.000242	0.00226	CcSEcCtD
Mianserin—Cardiac arrest—Dexamethasone—atopic dermatitis	0.000241	0.00225	CcSEcCtD
Mianserin—Cardiac arrest—Betamethasone—atopic dermatitis	0.000241	0.00225	CcSEcCtD
Mianserin—Weight increased—Prednisolone—atopic dermatitis	0.000239	0.00223	CcSEcCtD
Mianserin—Dry mouth—Tacrolimus—atopic dermatitis	0.000238	0.00223	CcSEcCtD
Mianserin—Confusional state—Tacrolimus—atopic dermatitis	0.000236	0.0022	CcSEcCtD
Mianserin—Oedema—Tacrolimus—atopic dermatitis	0.000234	0.00219	CcSEcCtD
Mianserin—Weight increased—Hydrocortisone—atopic dermatitis	0.000233	0.00218	CcSEcCtD
Mianserin—Shock—Tacrolimus—atopic dermatitis	0.00023	0.00215	CcSEcCtD
Mianserin—Nervous system disorder—Tacrolimus—atopic dermatitis	0.000229	0.00214	CcSEcCtD
Mianserin—Thrombocytopenia—Tacrolimus—atopic dermatitis	0.000229	0.00214	CcSEcCtD
Mianserin—Tachycardia—Tacrolimus—atopic dermatitis	0.000228	0.00213	CcSEcCtD
Mianserin—Skin disorder—Tacrolimus—atopic dermatitis	0.000227	0.00212	CcSEcCtD
Mianserin—Dizziness—Loratadine—atopic dermatitis	0.000226	0.00212	CcSEcCtD
Mianserin—Cardiac failure—Prednisone—atopic dermatitis	0.000226	0.00211	CcSEcCtD
Mianserin—Lethargy—Prednisone—atopic dermatitis	0.000225	0.00211	CcSEcCtD
Mianserin—Weight increased—Triamcinolone—atopic dermatitis	0.00022	0.00205	CcSEcCtD
Mianserin—Weight increased—Methylprednisolone—atopic dermatitis	0.000219	0.00205	CcSEcCtD
Mianserin—Hypotension—Tacrolimus—atopic dermatitis	0.000218	0.00204	CcSEcCtD
Mianserin—Pruritus—Fluocinolone Acetonide—atopic dermatitis	0.000217	0.00203	CcSEcCtD
Mianserin—Rash—Loratadine—atopic dermatitis	0.000216	0.00202	CcSEcCtD
Mianserin—Dermatitis—Loratadine—atopic dermatitis	0.000215	0.00202	CcSEcCtD
Mianserin—Headache—Loratadine—atopic dermatitis	0.000214	0.002	CcSEcCtD
Mianserin—Bradycardia—Prednisolone—atopic dermatitis	0.000214	0.002	CcSEcCtD
Mianserin—Musculoskeletal discomfort—Tacrolimus—atopic dermatitis	0.000213	0.00199	CcSEcCtD
Mianserin—Asthenia—Mometasone—atopic dermatitis	0.000211	0.00197	CcSEcCtD
Mianserin—Cardiac arrest—Prednisone—atopic dermatitis	0.00021	0.00196	CcSEcCtD
Mianserin—Paraesthesia—Tacrolimus—atopic dermatitis	0.00021	0.00196	CcSEcCtD
Mianserin—Bradycardia—Hydrocortisone—atopic dermatitis	0.000209	0.00195	CcSEcCtD
Mianserin—Somnolence—Tacrolimus—atopic dermatitis	0.000208	0.00194	CcSEcCtD
Mianserin—Pruritus—Mometasone—atopic dermatitis	0.000208	0.00194	CcSEcCtD
Mianserin—Dizziness—Fluocinolone Acetonide—atopic dermatitis	0.000203	0.0019	CcSEcCtD
Mianserin—Gastrointestinal disorder—Tacrolimus—atopic dermatitis	0.000202	0.00189	CcSEcCtD
Mianserin—Connective tissue disorder—Hydrocortisone—atopic dermatitis	0.000202	0.00189	CcSEcCtD
Mianserin—Fatigue—Tacrolimus—atopic dermatitis	0.000201	0.00188	CcSEcCtD
Mianserin—Constipation—Tacrolimus—atopic dermatitis	0.0002	0.00187	CcSEcCtD
Mianserin—Weight increased—Betamethasone—atopic dermatitis	0.000199	0.00186	CcSEcCtD
Mianserin—Weight increased—Dexamethasone—atopic dermatitis	0.000199	0.00186	CcSEcCtD
Mianserin—Bradycardia—Triamcinolone—atopic dermatitis	0.000197	0.00184	CcSEcCtD
Mianserin—Bradycardia—Methylprednisolone—atopic dermatitis	0.000196	0.00184	CcSEcCtD
Mianserin—Rash—Fluocinolone Acetonide—atopic dermatitis	0.000194	0.00181	CcSEcCtD
Mianserin—Dermatitis—Fluocinolone Acetonide—atopic dermatitis	0.000194	0.00181	CcSEcCtD
Mianserin—Headache—Fluocinolone Acetonide—atopic dermatitis	0.000193	0.0018	CcSEcCtD
Mianserin—Feeling abnormal—Tacrolimus—atopic dermatitis	0.000192	0.0018	CcSEcCtD
Mianserin—Eye disorder—Hydrocortisone—atopic dermatitis	0.000192	0.00179	CcSEcCtD
Mianserin—Connective tissue disorder—Methylprednisolone—atopic dermatitis	0.000189	0.00177	CcSEcCtD
Mianserin—Rash—Mometasone—atopic dermatitis	0.000185	0.00173	CcSEcCtD
Mianserin—Dermatitis—Mometasone—atopic dermatitis	0.000185	0.00173	CcSEcCtD
Mianserin—Headache—Mometasone—atopic dermatitis	0.000184	0.00172	CcSEcCtD
Mianserin—Eye disorder—Methylprednisolone—atopic dermatitis	0.00018	0.00168	CcSEcCtD
Mianserin—Mental disorder—Hydrocortisone—atopic dermatitis	0.00018	0.00168	CcSEcCtD
Mianserin—Cardiac disorder—Methylprednisolone—atopic dermatitis	0.000179	0.00167	CcSEcCtD
Mianserin—Bradycardia—Dexamethasone—atopic dermatitis	0.000178	0.00167	CcSEcCtD
Mianserin—Bradycardia—Betamethasone—atopic dermatitis	0.000178	0.00167	CcSEcCtD
Mianserin—Neutropenia—Prednisone—atopic dermatitis	0.000178	0.00167	CcSEcCtD
Mianserin—Erectile dysfunction—Prednisone—atopic dermatitis	0.000176	0.00164	CcSEcCtD
Mianserin—Angiopathy—Methylprednisolone—atopic dermatitis	0.000175	0.00164	CcSEcCtD
Mianserin—Mediastinal disorder—Methylprednisolone—atopic dermatitis	0.000174	0.00162	CcSEcCtD
Mianserin—Weight increased—Prednisone—atopic dermatitis	0.000173	0.00162	CcSEcCtD
Mianserin—Mental disorder—Methylprednisolone—atopic dermatitis	0.000169	0.00158	CcSEcCtD
Mianserin—Asthenia—Tacrolimus—atopic dermatitis	0.000168	0.00157	CcSEcCtD
Mianserin—Pruritus—Tacrolimus—atopic dermatitis	0.000165	0.00155	CcSEcCtD
Mianserin—Vertigo—Prednisolone—atopic dermatitis	0.000164	0.00154	CcSEcCtD
Mianserin—Syncope—Prednisolone—atopic dermatitis	0.000164	0.00153	CcSEcCtD
Mianserin—Eye disorder—Betamethasone—atopic dermatitis	0.000164	0.00153	CcSEcCtD
Mianserin—Eye disorder—Dexamethasone—atopic dermatitis	0.000164	0.00153	CcSEcCtD
Mianserin—Loss of consciousness—Prednisolone—atopic dermatitis	0.000161	0.0015	CcSEcCtD
Mianserin—Vertigo—Hydrocortisone—atopic dermatitis	0.00016	0.0015	CcSEcCtD
Mianserin—Syncope—Hydrocortisone—atopic dermatitis	0.00016	0.0015	CcSEcCtD
Mianserin—Angiopathy—Betamethasone—atopic dermatitis	0.000159	0.00149	CcSEcCtD
Mianserin—Angiopathy—Dexamethasone—atopic dermatitis	0.000159	0.00149	CcSEcCtD
Mianserin—Convulsion—Prednisolone—atopic dermatitis	0.000158	0.00148	CcSEcCtD
Mianserin—Hypertension—Prednisolone—atopic dermatitis	0.000158	0.00148	CcSEcCtD
Mianserin—Loss of consciousness—Hydrocortisone—atopic dermatitis	0.000157	0.00147	CcSEcCtD
Mianserin—Bradycardia—Prednisone—atopic dermatitis	0.000155	0.00145	CcSEcCtD
Mianserin—Convulsion—Hydrocortisone—atopic dermatitis	0.000155	0.00145	CcSEcCtD
Mianserin—Dizziness—Tacrolimus—atopic dermatitis	0.000154	0.00145	CcSEcCtD
Mianserin—Hypertension—Hydrocortisone—atopic dermatitis	0.000154	0.00144	CcSEcCtD
Mianserin—Myalgia—Hydrocortisone—atopic dermatitis	0.000152	0.00142	CcSEcCtD
Mianserin—Vertigo—Triamcinolone—atopic dermatitis	0.000151	0.00141	CcSEcCtD
Mianserin—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—atopic dermatitis	0.000151	0.00141	CcSEcCtD
Mianserin—Syncope—Triamcinolone—atopic dermatitis	0.000151	0.00141	CcSEcCtD
Mianserin—Vertigo—Methylprednisolone—atopic dermatitis	0.000151	0.00141	CcSEcCtD
Mianserin—Syncope—Methylprednisolone—atopic dermatitis	0.00015	0.00141	CcSEcCtD
Mianserin—Connective tissue disorder—Prednisone—atopic dermatitis	0.00015	0.0014	CcSEcCtD
Mianserin—Oedema—Prednisolone—atopic dermatitis	0.000149	0.0014	CcSEcCtD
Mianserin—Loss of consciousness—Triamcinolone—atopic dermatitis	0.000148	0.00138	CcSEcCtD
Mianserin—Loss of consciousness—Methylprednisolone—atopic dermatitis	0.000147	0.00138	CcSEcCtD
Mianserin—Rash—Tacrolimus—atopic dermatitis	0.000147	0.00138	CcSEcCtD
Mianserin—Dermatitis—Tacrolimus—atopic dermatitis	0.000147	0.00138	CcSEcCtD
Mianserin—Shock—Prednisolone—atopic dermatitis	0.000147	0.00137	CcSEcCtD
Mianserin—Headache—Tacrolimus—atopic dermatitis	0.000146	0.00137	CcSEcCtD
Mianserin—Oedema—Hydrocortisone—atopic dermatitis	0.000146	0.00136	CcSEcCtD
Mianserin—Convulsion—Triamcinolone—atopic dermatitis	0.000146	0.00136	CcSEcCtD
Mianserin—Tachycardia—Prednisolone—atopic dermatitis	0.000146	0.00136	CcSEcCtD
Mianserin—Convulsion—Methylprednisolone—atopic dermatitis	0.000145	0.00136	CcSEcCtD
Mianserin—Hypertension—Triamcinolone—atopic dermatitis	0.000145	0.00136	CcSEcCtD
Mianserin—Hypertension—Methylprednisolone—atopic dermatitis	0.000145	0.00136	CcSEcCtD
Mianserin—Shock—Hydrocortisone—atopic dermatitis	0.000143	0.00134	CcSEcCtD
Mianserin—Myalgia—Triamcinolone—atopic dermatitis	0.000143	0.00134	CcSEcCtD
Mianserin—Nervous system disorder—Hydrocortisone—atopic dermatitis	0.000143	0.00134	CcSEcCtD
Mianserin—Arthralgia—Methylprednisolone—atopic dermatitis	0.000143	0.00134	CcSEcCtD
Mianserin—Myalgia—Methylprednisolone—atopic dermatitis	0.000143	0.00134	CcSEcCtD
Mianserin—Eye disorder—Prednisone—atopic dermatitis	0.000143	0.00133	CcSEcCtD
Mianserin—Tachycardia—Hydrocortisone—atopic dermatitis	0.000142	0.00133	CcSEcCtD
Mianserin—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—atopic dermatitis	0.000142	0.00133	CcSEcCtD
Mianserin—Skin disorder—Hydrocortisone—atopic dermatitis	0.000142	0.00132	CcSEcCtD
Mianserin—Dry mouth—Triamcinolone—atopic dermatitis	0.00014	0.00131	CcSEcCtD
Mianserin—Angiopathy—Prednisone—atopic dermatitis	0.000138	0.0013	CcSEcCtD
Mianserin—Confusional state—Methylprednisolone—atopic dermatitis	0.000138	0.00129	CcSEcCtD
Mianserin—Oedema—Triamcinolone—atopic dermatitis	0.000137	0.00128	CcSEcCtD
Mianserin—Vertigo—Betamethasone—atopic dermatitis	0.000137	0.00128	CcSEcCtD
Mianserin—Vertigo—Dexamethasone—atopic dermatitis	0.000137	0.00128	CcSEcCtD
Mianserin—Syncope—Betamethasone—atopic dermatitis	0.000137	0.00128	CcSEcCtD
Mianserin—Syncope—Dexamethasone—atopic dermatitis	0.000137	0.00128	CcSEcCtD
Mianserin—Hypotension—Hydrocortisone—atopic dermatitis	0.000136	0.00127	CcSEcCtD
Mianserin—Shock—Triamcinolone—atopic dermatitis	0.000135	0.00126	CcSEcCtD
Mianserin—Shock—Methylprednisolone—atopic dermatitis	0.000135	0.00126	CcSEcCtD
Mianserin—Nervous system disorder—Methylprednisolone—atopic dermatitis	0.000134	0.00126	CcSEcCtD
Mianserin—Loss of consciousness—Dexamethasone—atopic dermatitis	0.000134	0.00125	CcSEcCtD
Mianserin—Loss of consciousness—Betamethasone—atopic dermatitis	0.000134	0.00125	CcSEcCtD
Mianserin—Paraesthesia—Prednisolone—atopic dermatitis	0.000134	0.00125	CcSEcCtD
Mianserin—Tachycardia—Triamcinolone—atopic dermatitis	0.000134	0.00125	CcSEcCtD
Mianserin—Mental disorder—Prednisone—atopic dermatitis	0.000134	0.00125	CcSEcCtD
Mianserin—Tachycardia—Methylprednisolone—atopic dermatitis	0.000134	0.00125	CcSEcCtD
Mianserin—Skin disorder—Methylprednisolone—atopic dermatitis	0.000133	0.00124	CcSEcCtD
Mianserin—Musculoskeletal discomfort—Hydrocortisone—atopic dermatitis	0.000133	0.00124	CcSEcCtD
Mianserin—Convulsion—Betamethasone—atopic dermatitis	0.000132	0.00124	CcSEcCtD
Mianserin—Convulsion—Dexamethasone—atopic dermatitis	0.000132	0.00124	CcSEcCtD
Mianserin—Hypertension—Betamethasone—atopic dermatitis	0.000132	0.00123	CcSEcCtD
Mianserin—Hypertension—Dexamethasone—atopic dermatitis	0.000132	0.00123	CcSEcCtD
Mianserin—Paraesthesia—Hydrocortisone—atopic dermatitis	0.000131	0.00122	CcSEcCtD
Mianserin—Myalgia—Dexamethasone—atopic dermatitis	0.00013	0.00122	CcSEcCtD
Mianserin—Myalgia—Betamethasone—atopic dermatitis	0.00013	0.00122	CcSEcCtD
Mianserin—Hypotension—Methylprednisolone—atopic dermatitis	0.000128	0.0012	CcSEcCtD
Mianserin—Gastrointestinal disorder—Hydrocortisone—atopic dermatitis	0.000126	0.00118	CcSEcCtD
Mianserin—Fatigue—Hydrocortisone—atopic dermatitis	0.000126	0.00118	CcSEcCtD
Mianserin—Musculoskeletal discomfort—Triamcinolone—atopic dermatitis	0.000125	0.00117	CcSEcCtD
Mianserin—Musculoskeletal discomfort—Methylprednisolone—atopic dermatitis	0.000125	0.00117	CcSEcCtD
Mianserin—Oedema—Betamethasone—atopic dermatitis	0.000124	0.00116	CcSEcCtD
Mianserin—Oedema—Dexamethasone—atopic dermatitis	0.000124	0.00116	CcSEcCtD
Mianserin—Paraesthesia—Triamcinolone—atopic dermatitis	0.000123	0.00115	CcSEcCtD
Mianserin—Feeling abnormal—Prednisolone—atopic dermatitis	0.000123	0.00115	CcSEcCtD
Mianserin—Paraesthesia—Methylprednisolone—atopic dermatitis	0.000123	0.00115	CcSEcCtD
Mianserin—Anaemia—Prednisone—atopic dermatitis	0.000123	0.00115	CcSEcCtD
Mianserin—Shock—Dexamethasone—atopic dermatitis	0.000122	0.00115	CcSEcCtD
Mianserin—Shock—Betamethasone—atopic dermatitis	0.000122	0.00115	CcSEcCtD
Mianserin—Nervous system disorder—Betamethasone—atopic dermatitis	0.000122	0.00114	CcSEcCtD
Mianserin—Nervous system disorder—Dexamethasone—atopic dermatitis	0.000122	0.00114	CcSEcCtD
Mianserin—Agitation—Prednisone—atopic dermatitis	0.000122	0.00114	CcSEcCtD
Mianserin—Thrombocytopenia—Dexamethasone—atopic dermatitis	0.000122	0.00114	CcSEcCtD
Mianserin—Thrombocytopenia—Betamethasone—atopic dermatitis	0.000122	0.00114	CcSEcCtD
Mianserin—Tachycardia—Betamethasone—atopic dermatitis	0.000121	0.00114	CcSEcCtD
Mianserin—Tachycardia—Dexamethasone—atopic dermatitis	0.000121	0.00114	CcSEcCtD
Mianserin—Feeling abnormal—Hydrocortisone—atopic dermatitis	0.00012	0.00112	CcSEcCtD
Mianserin—Vertigo—Prednisone—atopic dermatitis	0.000119	0.00112	CcSEcCtD
Mianserin—Syncope—Prednisone—atopic dermatitis	0.000119	0.00111	CcSEcCtD
Mianserin—Fatigue—Triamcinolone—atopic dermatitis	0.000118	0.00111	CcSEcCtD
Mianserin—Fatigue—Methylprednisolone—atopic dermatitis	0.000118	0.0011	CcSEcCtD
Mianserin—Loss of consciousness—Prednisone—atopic dermatitis	0.000117	0.00109	CcSEcCtD
Mianserin—Hypotension—Dexamethasone—atopic dermatitis	0.000116	0.00109	CcSEcCtD
Mianserin—Hypotension—Betamethasone—atopic dermatitis	0.000116	0.00109	CcSEcCtD
Mianserin—Convulsion—Prednisone—atopic dermatitis	0.000115	0.00108	CcSEcCtD
Mianserin—Hypertension—Prednisone—atopic dermatitis	0.000115	0.00107	CcSEcCtD
Mianserin—Musculoskeletal discomfort—Betamethasone—atopic dermatitis	0.000113	0.00106	CcSEcCtD
Mianserin—Musculoskeletal discomfort—Dexamethasone—atopic dermatitis	0.000113	0.00106	CcSEcCtD
Mianserin—Arthralgia—Prednisone—atopic dermatitis	0.000113	0.00106	CcSEcCtD
Mianserin—Myalgia—Prednisone—atopic dermatitis	0.000113	0.00106	CcSEcCtD
Mianserin—Feeling abnormal—Triamcinolone—atopic dermatitis	0.000113	0.00106	CcSEcCtD
Mianserin—Feeling abnormal—Methylprednisolone—atopic dermatitis	0.000113	0.00106	CcSEcCtD
Mianserin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—atopic dermatitis	0.000112	0.00105	CcSEcCtD
Mianserin—Paraesthesia—Betamethasone—atopic dermatitis	0.000112	0.00105	CcSEcCtD
Mianserin—Paraesthesia—Dexamethasone—atopic dermatitis	0.000112	0.00105	CcSEcCtD
Mianserin—Oedema—Prednisone—atopic dermatitis	0.000108	0.00101	CcSEcCtD
Mianserin—Gastrointestinal disorder—Betamethasone—atopic dermatitis	0.000107	0.00101	CcSEcCtD
Mianserin—Gastrointestinal disorder—Dexamethasone—atopic dermatitis	0.000107	0.00101	CcSEcCtD
Mianserin—Fatigue—Dexamethasone—atopic dermatitis	0.000107	0.001	CcSEcCtD
Mianserin—Fatigue—Betamethasone—atopic dermatitis	0.000107	0.001	CcSEcCtD
Mianserin—Shock—Prednisone—atopic dermatitis	0.000107	0.000998	CcSEcCtD
Mianserin—Nervous system disorder—Prednisone—atopic dermatitis	0.000106	0.000995	CcSEcCtD
Mianserin—Tachycardia—Prednisone—atopic dermatitis	0.000106	0.00099	CcSEcCtD
Mianserin—Skin disorder—Prednisone—atopic dermatitis	0.000105	0.000985	CcSEcCtD
Mianserin—Asthenia—Hydrocortisone—atopic dermatitis	0.000105	0.000978	CcSEcCtD
Mianserin—Pruritus—Hydrocortisone—atopic dermatitis	0.000103	0.000965	CcSEcCtD
Mianserin—Feeling abnormal—Dexamethasone—atopic dermatitis	0.000103	0.00096	CcSEcCtD
Mianserin—Feeling abnormal—Betamethasone—atopic dermatitis	0.000103	0.00096	CcSEcCtD
Mianserin—Musculoskeletal discomfort—Prednisone—atopic dermatitis	9.88e-05	0.000924	CcSEcCtD
Mianserin—Dizziness—Prednisolone—atopic dermatitis	9.87e-05	0.000923	CcSEcCtD
Mianserin—Asthenia—Triamcinolone—atopic dermatitis	9.84e-05	0.000921	CcSEcCtD
Mianserin—Asthenia—Methylprednisolone—atopic dermatitis	9.82e-05	0.000919	CcSEcCtD
Mianserin—Paraesthesia—Prednisone—atopic dermatitis	9.73e-05	0.000911	CcSEcCtD
Mianserin—Pruritus—Triamcinolone—atopic dermatitis	9.71e-05	0.000908	CcSEcCtD
Mianserin—Pruritus—Methylprednisolone—atopic dermatitis	9.69e-05	0.000906	CcSEcCtD
Mianserin—Dizziness—Hydrocortisone—atopic dermatitis	9.64e-05	0.000902	CcSEcCtD
Mianserin—Rash—Prednisolone—atopic dermatitis	9.41e-05	0.00088	CcSEcCtD
Mianserin—Dermatitis—Prednisolone—atopic dermatitis	9.4e-05	0.000879	CcSEcCtD
Mianserin—Fatigue—Prednisone—atopic dermatitis	9.35e-05	0.000875	CcSEcCtD
Mianserin—Headache—Prednisolone—atopic dermatitis	9.35e-05	0.000875	CcSEcCtD
Mianserin—Constipation—Prednisone—atopic dermatitis	9.27e-05	0.000867	CcSEcCtD
Mianserin—Rash—Hydrocortisone—atopic dermatitis	9.19e-05	0.00086	CcSEcCtD
Mianserin—Dermatitis—Hydrocortisone—atopic dermatitis	9.18e-05	0.000859	CcSEcCtD
Mianserin—Headache—Hydrocortisone—atopic dermatitis	9.13e-05	0.000854	CcSEcCtD
Mianserin—Dizziness—Triamcinolone—atopic dermatitis	9.07e-05	0.000849	CcSEcCtD
Mianserin—Dizziness—Methylprednisolone—atopic dermatitis	9.05e-05	0.000847	CcSEcCtD
Mianserin—Feeling abnormal—Prednisone—atopic dermatitis	8.93e-05	0.000836	CcSEcCtD
Mianserin—Asthenia—Dexamethasone—atopic dermatitis	8.93e-05	0.000836	CcSEcCtD
Mianserin—Asthenia—Betamethasone—atopic dermatitis	8.93e-05	0.000836	CcSEcCtD
Mianserin—Pruritus—Dexamethasone—atopic dermatitis	8.81e-05	0.000824	CcSEcCtD
Mianserin—Pruritus—Betamethasone—atopic dermatitis	8.81e-05	0.000824	CcSEcCtD
Mianserin—Rash—Triamcinolone—atopic dermatitis	8.65e-05	0.000809	CcSEcCtD
Mianserin—Dermatitis—Triamcinolone—atopic dermatitis	8.64e-05	0.000809	CcSEcCtD
Mianserin—Rash—Methylprednisolone—atopic dermatitis	8.63e-05	0.000808	CcSEcCtD
Mianserin—Dermatitis—Methylprednisolone—atopic dermatitis	8.62e-05	0.000807	CcSEcCtD
Mianserin—Headache—Triamcinolone—atopic dermatitis	8.59e-05	0.000804	CcSEcCtD
Mianserin—Headache—Methylprednisolone—atopic dermatitis	8.58e-05	0.000802	CcSEcCtD
Mianserin—Dizziness—Dexamethasone—atopic dermatitis	8.23e-05	0.00077	CcSEcCtD
Mianserin—Dizziness—Betamethasone—atopic dermatitis	8.23e-05	0.00077	CcSEcCtD
Mianserin—Rash—Betamethasone—atopic dermatitis	7.85e-05	0.000734	CcSEcCtD
Mianserin—Rash—Dexamethasone—atopic dermatitis	7.85e-05	0.000734	CcSEcCtD
Mianserin—Dermatitis—Betamethasone—atopic dermatitis	7.84e-05	0.000734	CcSEcCtD
Mianserin—Dermatitis—Dexamethasone—atopic dermatitis	7.84e-05	0.000734	CcSEcCtD
Mianserin—Headache—Dexamethasone—atopic dermatitis	7.8e-05	0.00073	CcSEcCtD
Mianserin—Headache—Betamethasone—atopic dermatitis	7.8e-05	0.00073	CcSEcCtD
Mianserin—Asthenia—Prednisone—atopic dermatitis	7.78e-05	0.000728	CcSEcCtD
Mianserin—Pruritus—Prednisone—atopic dermatitis	7.67e-05	0.000718	CcSEcCtD
Mianserin—Dizziness—Prednisone—atopic dermatitis	7.17e-05	0.000671	CcSEcCtD
Mianserin—Rash—Prednisone—atopic dermatitis	6.84e-05	0.00064	CcSEcCtD
Mianserin—Dermatitis—Prednisone—atopic dermatitis	6.83e-05	0.000639	CcSEcCtD
Mianserin—Headache—Prednisone—atopic dermatitis	6.79e-05	0.000635	CcSEcCtD
Mianserin—ADRA2C—Signaling Pathways—NPS—atopic dermatitis	1.19e-05	0.000177	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—CCR3—atopic dermatitis	1.19e-05	0.000177	CbGpPWpGaD
Mianserin—ADRA2A—GPCR ligand binding—CXCL8—atopic dermatitis	1.19e-05	0.000176	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—IL5—atopic dermatitis	1.19e-05	0.000176	CbGpPWpGaD
Mianserin—OPRK1—GPCR downstream signaling—CXCL8—atopic dermatitis	1.17e-05	0.000174	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—CXCR3—atopic dermatitis	1.17e-05	0.000174	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—GLB1—atopic dermatitis	1.16e-05	0.000173	CbGpPWpGaD
Mianserin—HTR6—GPCR downstream signaling—CXCL8—atopic dermatitis	1.15e-05	0.000171	CbGpPWpGaD
Mianserin—OPRK1—Signaling Pathways—CCL5—atopic dermatitis	1.15e-05	0.000171	CbGpPWpGaD
Mianserin—HTR7—GPCR downstream signaling—CXCL8—atopic dermatitis	1.15e-05	0.000171	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—IL5—atopic dermatitis	1.15e-05	0.00017	CbGpPWpGaD
Mianserin—HTR1D—GPCR downstream signaling—CXCL8—atopic dermatitis	1.15e-05	0.00017	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—IL5—atopic dermatitis	1.14e-05	0.000169	CbGpPWpGaD
Mianserin—HTR6—Signaling Pathways—CCL5—atopic dermatitis	1.14e-05	0.000169	CbGpPWpGaD
Mianserin—HTR7—Signaling Pathways—CCL5—atopic dermatitis	1.14e-05	0.000169	CbGpPWpGaD
Mianserin—HRH2—Signaling Pathways—NFKBIA—atopic dermatitis	1.13e-05	0.000168	CbGpPWpGaD
Mianserin—HTR1D—Signaling Pathways—CCL5—atopic dermatitis	1.13e-05	0.000167	CbGpPWpGaD
Mianserin—DRD2—Signaling by GPCR—CCR5—atopic dermatitis	1.13e-05	0.000167	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—CXCL10—atopic dermatitis	1.12e-05	0.000167	CbGpPWpGaD
Mianserin—ADRA2A—Signaling by GPCR—CCL5—atopic dermatitis	1.12e-05	0.000166	CbGpPWpGaD
Mianserin—OPRK1—GPCR downstream signaling—IL2—atopic dermatitis	1.12e-05	0.000166	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—ADSL—atopic dermatitis	1.11e-05	0.000165	CbGpPWpGaD
Mianserin—ADRA2A—GPCR downstream signaling—CCR5—atopic dermatitis	1.11e-05	0.000165	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—IL5—atopic dermatitis	1.11e-05	0.000165	CbGpPWpGaD
Mianserin—HTR2A—Signaling by GPCR—CCR5—atopic dermatitis	1.11e-05	0.000165	CbGpPWpGaD
Mianserin—HRH1—Signaling by GPCR—CCR5—atopic dermatitis	1.11e-05	0.000164	CbGpPWpGaD
Mianserin—HTR6—GPCR downstream signaling—IL2—atopic dermatitis	1.1e-05	0.000164	CbGpPWpGaD
Mianserin—HTR7—GPCR downstream signaling—IL2—atopic dermatitis	1.1e-05	0.000164	CbGpPWpGaD
Mianserin—HTR1D—GPCR downstream signaling—IL2—atopic dermatitis	1.09e-05	0.000163	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—CCR3—atopic dermatitis	1.09e-05	0.000161	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—NPS—atopic dermatitis	1.08e-05	0.000161	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—TAC1—atopic dermatitis	1.08e-05	0.000161	CbGpPWpGaD
Mianserin—OPRK1—Signaling Pathways—NGF—atopic dermatitis	1.07e-05	0.000159	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—NPS—atopic dermatitis	1.07e-05	0.000158	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—TAC1—atopic dermatitis	1.07e-05	0.000158	CbGpPWpGaD
Mianserin—OPRK1—Signaling by GPCR—CXCL8—atopic dermatitis	1.06e-05	0.000158	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—TAC1—atopic dermatitis	1.06e-05	0.000158	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—NPS—atopic dermatitis	1.06e-05	0.000158	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—CXCR3—atopic dermatitis	1.06e-05	0.000158	CbGpPWpGaD
Mianserin—HTR2B—GPCR downstream signaling—CXCL8—atopic dermatitis	1.05e-05	0.000156	CbGpPWpGaD
Mianserin—HTR6—Signaling Pathways—NGF—atopic dermatitis	1.05e-05	0.000156	CbGpPWpGaD
Mianserin—HTR7—Signaling Pathways—NGF—atopic dermatitis	1.05e-05	0.000156	CbGpPWpGaD
Mianserin—HTR6—Signaling by GPCR—CXCL8—atopic dermatitis	1.05e-05	0.000156	CbGpPWpGaD
Mianserin—HTR7—Signaling by GPCR—CXCL8—atopic dermatitis	1.05e-05	0.000155	CbGpPWpGaD
Mianserin—HTR1D—Signaling Pathways—NGF—atopic dermatitis	1.04e-05	0.000155	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—CXCR3—atopic dermatitis	1.04e-05	0.000155	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—CXCR3—atopic dermatitis	1.04e-05	0.000155	CbGpPWpGaD
Mianserin—HRH4—Signaling Pathways—CXCL8—atopic dermatitis	1.04e-05	0.000155	CbGpPWpGaD
Mianserin—HTR1D—Signaling by GPCR—CXCL8—atopic dermatitis	1.04e-05	0.000154	CbGpPWpGaD
Mianserin—OPRK1—Signaling Pathways—CCR5—atopic dermatitis	1.04e-05	0.000154	CbGpPWpGaD
Mianserin—HTR2B—Signaling Pathways—CCL5—atopic dermatitis	1.04e-05	0.000154	CbGpPWpGaD
Mianserin—HTR6—Signaling Pathways—CCR5—atopic dermatitis	1.02e-05	0.000152	CbGpPWpGaD
Mianserin—HTR7—Signaling Pathways—CCR5—atopic dermatitis	1.02e-05	0.000152	CbGpPWpGaD
Mianserin—OPRK1—Signaling by GPCR—IL2—atopic dermatitis	1.02e-05	0.000151	CbGpPWpGaD
Mianserin—HTR1D—Signaling Pathways—CCR5—atopic dermatitis	1.02e-05	0.000151	CbGpPWpGaD
Mianserin—ADRA2A—Hemostasis—IL2—atopic dermatitis	1.02e-05	0.000151	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—CXCL10—atopic dermatitis	1.01e-05	0.00015	CbGpPWpGaD
Mianserin—ADRA2A—Signaling by GPCR—CCR5—atopic dermatitis	1.01e-05	0.00015	CbGpPWpGaD
Mianserin—HTR2B—GPCR downstream signaling—IL2—atopic dermatitis	1.01e-05	0.000149	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—IL5—atopic dermatitis	1.01e-05	0.000149	CbGpPWpGaD
Mianserin—HTR6—Signaling by GPCR—IL2—atopic dermatitis	1e-05	0.000149	CbGpPWpGaD
Mianserin—HTR7—Signaling by GPCR—IL2—atopic dermatitis	1e-05	0.000149	CbGpPWpGaD
Mianserin—HRH4—Signaling Pathways—IL2—atopic dermatitis	9.95e-06	0.000148	CbGpPWpGaD
Mianserin—HTR1D—Signaling by GPCR—IL2—atopic dermatitis	9.94e-06	0.000148	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—IL5—atopic dermatitis	9.9e-06	0.000147	CbGpPWpGaD
Mianserin—HRH4—Signaling by GPCR—IL6—atopic dermatitis	9.9e-06	0.000147	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—IL5—atopic dermatitis	9.88e-06	0.000147	CbGpPWpGaD
Mianserin—DRD3—GPCR downstream signaling—CXCL8—atopic dermatitis	9.8e-06	0.000146	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—CXCL10—atopic dermatitis	9.78e-06	0.000145	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—CXCL10—atopic dermatitis	9.73e-06	0.000144	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—NPS—atopic dermatitis	9.69e-06	0.000144	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—TAC1—atopic dermatitis	9.69e-06	0.000144	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—CCL5—atopic dermatitis	9.66e-06	0.000143	CbGpPWpGaD
Mianserin—HTR2B—Signaling Pathways—NGF—atopic dermatitis	9.61e-06	0.000143	CbGpPWpGaD
Mianserin—HTR1F—Signaling Pathways—CXCL8—atopic dermatitis	9.61e-06	0.000143	CbGpPWpGaD
Mianserin—HTR2B—Signaling by GPCR—CXCL8—atopic dermatitis	9.57e-06	0.000142	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—CXCR3—atopic dermatitis	9.51e-06	0.000141	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—CXCL10—atopic dermatitis	9.46e-06	0.00014	CbGpPWpGaD
Mianserin—DRD3—GPCR downstream signaling—IL2—atopic dermatitis	9.37e-06	0.000139	CbGpPWpGaD
Mianserin—HTR2B—Signaling Pathways—CCR5—atopic dermatitis	9.35e-06	0.000139	CbGpPWpGaD
Mianserin—HTR1F—Signaling Pathways—IL2—atopic dermatitis	9.18e-06	0.000136	CbGpPWpGaD
Mianserin—HRH4—Signaling Pathways—MAPK8—atopic dermatitis	9.16e-06	0.000136	CbGpPWpGaD
Mianserin—HTR2B—Signaling by GPCR—IL2—atopic dermatitis	9.14e-06	0.000136	CbGpPWpGaD
Mianserin—HTR1F—Signaling by GPCR—IL6—atopic dermatitis	9.14e-06	0.000136	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—IL5—atopic dermatitis	9.01e-06	0.000134	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—GLB1—atopic dermatitis	8.97e-06	0.000133	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—NGF—atopic dermatitis	8.94e-06	0.000133	CbGpPWpGaD
Mianserin—DRD3—Signaling by GPCR—CXCL8—atopic dermatitis	8.9e-06	0.000132	CbGpPWpGaD
Mianserin—ADRA2B—GPCR downstream signaling—CXCL8—atopic dermatitis	8.85e-06	0.000131	CbGpPWpGaD
Mianserin—OPRK1—Signaling Pathways—NFKBIA—atopic dermatitis	8.81e-06	0.000131	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—CCL5—atopic dermatitis	8.72e-06	0.000129	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—CCR5—atopic dermatitis	8.7e-06	0.000129	CbGpPWpGaD
Mianserin—HTR6—Signaling Pathways—NFKBIA—atopic dermatitis	8.68e-06	0.000129	CbGpPWpGaD
Mianserin—HTR7—Signaling Pathways—NFKBIA—atopic dermatitis	8.67e-06	0.000129	CbGpPWpGaD
Mianserin—HTR1D—Signaling Pathways—NFKBIA—atopic dermatitis	8.62e-06	0.000128	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—ADSL—atopic dermatitis	8.6e-06	0.000128	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—CXCL10—atopic dermatitis	8.58e-06	0.000127	CbGpPWpGaD
Mianserin—HTR1A—GPCR downstream signaling—CXCL8—atopic dermatitis	8.54e-06	0.000127	CbGpPWpGaD
Mianserin—DRD3—Signaling by GPCR—IL2—atopic dermatitis	8.51e-06	0.000126	CbGpPWpGaD
Mianserin—HTR2C—GPCR downstream signaling—CXCL8—atopic dermatitis	8.5e-06	0.000126	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	8.47e-06	0.000126	CbGpPWpGaD
Mianserin—ADRA2B—GPCR downstream signaling—IL2—atopic dermatitis	8.46e-06	0.000126	CbGpPWpGaD
Mianserin—HTR1F—Signaling Pathways—MAPK8—atopic dermatitis	8.45e-06	0.000125	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—CXCL10—atopic dermatitis	8.45e-06	0.000125	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—CXCL10—atopic dermatitis	8.43e-06	0.000125	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—CCL5—atopic dermatitis	8.41e-06	0.000125	CbGpPWpGaD
Mianserin—ADRA2C—Metabolism—PPARA—atopic dermatitis	8.41e-06	0.000125	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—CCL5—atopic dermatitis	8.37e-06	0.000124	CbGpPWpGaD
Mianserin—ADRA2C—GPCR downstream signaling—CXCL8—atopic dermatitis	8.27e-06	0.000123	CbGpPWpGaD
Mianserin—HTR1A—GPCR downstream signaling—IL2—atopic dermatitis	8.17e-06	0.000121	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—CCL5—atopic dermatitis	8.14e-06	0.000121	CbGpPWpGaD
Mianserin—HTR2C—GPCR downstream signaling—IL2—atopic dermatitis	8.12e-06	0.000121	CbGpPWpGaD
Mianserin—HRH2—Signaling Pathways—CXCL8—atopic dermatitis	8.07e-06	0.00012	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—NGF—atopic dermatitis	8.07e-06	0.00012	CbGpPWpGaD
Mianserin—ADRA2B—Signaling by GPCR—CXCL8—atopic dermatitis	8.04e-06	0.000119	CbGpPWpGaD
Mianserin—HTR2B—Signaling Pathways—NFKBIA—atopic dermatitis	7.93e-06	0.000118	CbGpPWpGaD
Mianserin—ADRA2C—GPCR downstream signaling—IL2—atopic dermatitis	7.9e-06	0.000117	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—CCR5—atopic dermatitis	7.85e-06	0.000117	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—NGF—atopic dermatitis	7.79e-06	0.000116	CbGpPWpGaD
Mianserin—HTR1A—Signaling by GPCR—CXCL8—atopic dermatitis	7.76e-06	0.000115	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—NGF—atopic dermatitis	7.75e-06	0.000115	CbGpPWpGaD
Mianserin—HTR2C—Signaling by GPCR—CXCL8—atopic dermatitis	7.72e-06	0.000115	CbGpPWpGaD
Mianserin—HRH2—Signaling Pathways—IL2—atopic dermatitis	7.72e-06	0.000115	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—CXCL10—atopic dermatitis	7.68e-06	0.000114	CbGpPWpGaD
Mianserin—ADRA2B—Signaling by GPCR—IL2—atopic dermatitis	7.68e-06	0.000114	CbGpPWpGaD
Mianserin—HRH2—Signaling by GPCR—IL6—atopic dermatitis	7.68e-06	0.000114	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—CCR5—atopic dermatitis	7.58e-06	0.000113	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—CCR5—atopic dermatitis	7.54e-06	0.000112	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—NGF—atopic dermatitis	7.54e-06	0.000112	CbGpPWpGaD
Mianserin—ADRA2C—Signaling by GPCR—CXCL8—atopic dermatitis	7.51e-06	0.000111	CbGpPWpGaD
Mianserin—DRD2—GPCR downstream signaling—CXCL8—atopic dermatitis	7.5e-06	0.000111	CbGpPWpGaD
Mianserin—HTR1A—Signaling by GPCR—IL2—atopic dermatitis	7.41e-06	0.00011	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—CCL5—atopic dermatitis	7.39e-06	0.00011	CbGpPWpGaD
Mianserin—HTR2A—GPCR downstream signaling—CXCL8—atopic dermatitis	7.38e-06	0.00011	CbGpPWpGaD
Mianserin—HTR2C—Signaling by GPCR—IL2—atopic dermatitis	7.38e-06	0.00011	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—NFKBIA—atopic dermatitis	7.37e-06	0.000109	CbGpPWpGaD
Mianserin—HRH1—GPCR downstream signaling—CXCL8—atopic dermatitis	7.37e-06	0.000109	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—CCR5—atopic dermatitis	7.34e-06	0.000109	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—CCL5—atopic dermatitis	7.27e-06	0.000108	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—CCL5—atopic dermatitis	7.25e-06	0.000108	CbGpPWpGaD
Mianserin—ADRA2C—Signaling by GPCR—IL2—atopic dermatitis	7.18e-06	0.000107	CbGpPWpGaD
Mianserin—DRD2—GPCR downstream signaling—IL2—atopic dermatitis	7.17e-06	0.000106	CbGpPWpGaD
Mianserin—HRH2—Signaling Pathways—MAPK8—atopic dermatitis	7.1e-06	0.000105	CbGpPWpGaD
Mianserin—HTR2A—GPCR downstream signaling—IL2—atopic dermatitis	7.05e-06	0.000105	CbGpPWpGaD
Mianserin—HRH1—GPCR downstream signaling—IL2—atopic dermatitis	7.04e-06	0.000105	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—NGF—atopic dermatitis	6.84e-06	0.000102	CbGpPWpGaD
Mianserin—ADRA2A—Metabolism—PPARA—atopic dermatitis	6.83e-06	0.000101	CbGpPWpGaD
Mianserin—DRD2—Signaling by GPCR—CXCL8—atopic dermatitis	6.81e-06	0.000101	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—NGF—atopic dermatitis	6.73e-06	0.0001	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—NGF—atopic dermatitis	6.72e-06	9.97e-05	CbGpPWpGaD
Mianserin—ADRA2A—GPCR downstream signaling—CXCL8—atopic dermatitis	6.72e-06	9.97e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling by GPCR—CXCL8—atopic dermatitis	6.7e-06	9.95e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling by GPCR—CXCL8—atopic dermatitis	6.69e-06	9.93e-05	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—NFKBIA—atopic dermatitis	6.66e-06	9.88e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—CCR5—atopic dermatitis	6.66e-06	9.88e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—CCL5—atopic dermatitis	6.61e-06	9.82e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—CCR5—atopic dermatitis	6.55e-06	9.72e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—CCR5—atopic dermatitis	6.54e-06	9.7e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling by GPCR—IL2—atopic dermatitis	6.51e-06	9.67e-05	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—NFKBIA—atopic dermatitis	6.43e-06	9.54e-05	CbGpPWpGaD
Mianserin—ADRA2A—GPCR downstream signaling—IL2—atopic dermatitis	6.42e-06	9.53e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling by GPCR—IL2—atopic dermatitis	6.41e-06	9.51e-05	CbGpPWpGaD
Mianserin—CYP2B6—Metabolism—PPARA—atopic dermatitis	6.41e-06	9.51e-05	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—NFKBIA—atopic dermatitis	6.39e-06	9.49e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling by GPCR—IL2—atopic dermatitis	6.39e-06	9.49e-05	CbGpPWpGaD
Mianserin—OPRK1—Signaling Pathways—CXCL8—atopic dermatitis	6.28e-06	9.33e-05	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—NFKBIA—atopic dermatitis	6.22e-06	9.23e-05	CbGpPWpGaD
Mianserin—HTR6—Signaling Pathways—CXCL8—atopic dermatitis	6.19e-06	9.19e-05	CbGpPWpGaD
Mianserin—HTR7—Signaling Pathways—CXCL8—atopic dermatitis	6.19e-06	9.18e-05	CbGpPWpGaD
Mianserin—HTR1D—Signaling Pathways—CXCL8—atopic dermatitis	6.14e-06	9.12e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—NGF—atopic dermatitis	6.13e-06	9.09e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling by GPCR—CXCL8—atopic dermatitis	6.1e-06	9.05e-05	CbGpPWpGaD
Mianserin—OPRK1—Signaling Pathways—IL2—atopic dermatitis	6e-06	8.91e-05	CbGpPWpGaD
Mianserin—OPRK1—Signaling by GPCR—IL6—atopic dermatitis	5.97e-06	8.87e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—CCR5—atopic dermatitis	5.96e-06	8.85e-05	CbGpPWpGaD
Mianserin—HTR6—Signaling Pathways—IL2—atopic dermatitis	5.92e-06	8.79e-05	CbGpPWpGaD
Mianserin—HTR7—Signaling Pathways—IL2—atopic dermatitis	5.91e-06	8.78e-05	CbGpPWpGaD
Mianserin—HTR6—Signaling by GPCR—IL6—atopic dermatitis	5.89e-06	8.74e-05	CbGpPWpGaD
Mianserin—HTR7—Signaling by GPCR—IL6—atopic dermatitis	5.88e-06	8.73e-05	CbGpPWpGaD
Mianserin—HTR1D—Signaling Pathways—IL2—atopic dermatitis	5.87e-06	8.72e-05	CbGpPWpGaD
Mianserin—HRH4—Signaling Pathways—IL6—atopic dermatitis	5.85e-06	8.68e-05	CbGpPWpGaD
Mianserin—HTR1D—Signaling by GPCR—IL6—atopic dermatitis	5.84e-06	8.67e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling by GPCR—IL2—atopic dermatitis	5.83e-06	8.65e-05	CbGpPWpGaD
Mianserin—HTR2B—Signaling Pathways—CXCL8—atopic dermatitis	5.65e-06	8.39e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—NFKBIA—atopic dermatitis	5.64e-06	8.38e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—NFKBIA—atopic dermatitis	5.55e-06	8.24e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—NFKBIA—atopic dermatitis	5.54e-06	8.23e-05	CbGpPWpGaD
Mianserin—OPRK1—Signaling Pathways—MAPK8—atopic dermatitis	5.53e-06	8.21e-05	CbGpPWpGaD
Mianserin—HTR6—Signaling Pathways—MAPK8—atopic dermatitis	5.45e-06	8.09e-05	CbGpPWpGaD
Mianserin—HTR7—Signaling Pathways—MAPK8—atopic dermatitis	5.44e-06	8.08e-05	CbGpPWpGaD
Mianserin—HTR1D—Signaling Pathways—MAPK8—atopic dermatitis	5.41e-06	8.02e-05	CbGpPWpGaD
Mianserin—HTR2B—Signaling Pathways—IL2—atopic dermatitis	5.4e-06	8.02e-05	CbGpPWpGaD
Mianserin—HTR1F—Signaling Pathways—IL6—atopic dermatitis	5.4e-06	8.01e-05	CbGpPWpGaD
Mianserin—HTR2B—Signaling by GPCR—IL6—atopic dermatitis	5.37e-06	7.98e-05	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—CXCL8—atopic dermatitis	5.26e-06	7.81e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—NFKBIA—atopic dermatitis	5.05e-06	7.5e-05	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—IL2—atopic dermatitis	5.03e-06	7.46e-05	CbGpPWpGaD
Mianserin—DRD3—Signaling by GPCR—IL6—atopic dermatitis	5e-06	7.42e-05	CbGpPWpGaD
Mianserin—HTR2B—Signaling Pathways—MAPK8—atopic dermatitis	4.97e-06	7.38e-05	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—CXCL8—atopic dermatitis	4.75e-06	7.05e-05	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—MAPK8—atopic dermatitis	4.63e-06	6.87e-05	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—CXCL8—atopic dermatitis	4.58e-06	6.8e-05	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—CXCL8—atopic dermatitis	4.56e-06	6.77e-05	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—IL2—atopic dermatitis	4.54e-06	6.74e-05	CbGpPWpGaD
Mianserin—HRH2—Signaling Pathways—IL6—atopic dermatitis	4.53e-06	6.73e-05	CbGpPWpGaD
Mianserin—ADRA2B—Signaling by GPCR—IL6—atopic dermatitis	4.51e-06	6.7e-05	CbGpPWpGaD
Mianserin—CYP2D6—Metabolism—PPARA—atopic dermatitis	4.45e-06	6.61e-05	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—CXCL8—atopic dermatitis	4.44e-06	6.58e-05	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—IL2—atopic dermatitis	4.38e-06	6.5e-05	CbGpPWpGaD
Mianserin—HTR1A—Signaling by GPCR—IL6—atopic dermatitis	4.36e-06	6.47e-05	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—IL2—atopic dermatitis	4.36e-06	6.47e-05	CbGpPWpGaD
Mianserin—HTR2C—Signaling by GPCR—IL6—atopic dermatitis	4.34e-06	6.44e-05	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—IL2—atopic dermatitis	4.24e-06	6.29e-05	CbGpPWpGaD
Mianserin—ADRA2C—Signaling by GPCR—IL6—atopic dermatitis	4.22e-06	6.26e-05	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—MAPK8—atopic dermatitis	4.18e-06	6.2e-05	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—MAPK8—atopic dermatitis	4.03e-06	5.99e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—CXCL8—atopic dermatitis	4.02e-06	5.97e-05	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—MAPK8—atopic dermatitis	4.01e-06	5.96e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—CXCL8—atopic dermatitis	3.96e-06	5.88e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—CXCL8—atopic dermatitis	3.95e-06	5.87e-05	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—MAPK8—atopic dermatitis	3.9e-06	5.79e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—IL2—atopic dermatitis	3.85e-06	5.71e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling by GPCR—IL6—atopic dermatitis	3.83e-06	5.68e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—IL2—atopic dermatitis	3.78e-06	5.62e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—IL2—atopic dermatitis	3.78e-06	5.61e-05	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—PPARA—atopic dermatitis	3.77e-06	5.6e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling by GPCR—IL6—atopic dermatitis	3.77e-06	5.59e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling by GPCR—IL6—atopic dermatitis	3.76e-06	5.58e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—CXCL8—atopic dermatitis	3.6e-06	5.35e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—MAPK8—atopic dermatitis	3.54e-06	5.26e-05	CbGpPWpGaD
Mianserin—OPRK1—Signaling Pathways—IL6—atopic dermatitis	3.53e-06	5.24e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—MAPK8—atopic dermatitis	3.48e-06	5.17e-05	CbGpPWpGaD
Mianserin—HTR6—Signaling Pathways—IL6—atopic dermatitis	3.48e-06	5.16e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—MAPK8—atopic dermatitis	3.48e-06	5.16e-05	CbGpPWpGaD
Mianserin—HTR7—Signaling Pathways—IL6—atopic dermatitis	3.47e-06	5.16e-05	CbGpPWpGaD
Mianserin—HTR1D—Signaling Pathways—IL6—atopic dermatitis	3.45e-06	5.12e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—IL2—atopic dermatitis	3.44e-06	5.11e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling by GPCR—IL6—atopic dermatitis	3.43e-06	5.09e-05	CbGpPWpGaD
Mianserin—HTR2B—Signaling Pathways—IL6—atopic dermatitis	3.17e-06	4.71e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—MAPK8—atopic dermatitis	3.17e-06	4.7e-05	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—IL6—atopic dermatitis	2.95e-06	4.39e-05	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—PPARA—atopic dermatitis	2.91e-06	4.32e-05	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—IL6—atopic dermatitis	2.67e-06	3.96e-05	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—IL6—atopic dermatitis	2.57e-06	3.82e-05	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—IL6—atopic dermatitis	2.56e-06	3.8e-05	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—IL6—atopic dermatitis	2.49e-06	3.7e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—IL6—atopic dermatitis	2.26e-06	3.36e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—IL6—atopic dermatitis	2.22e-06	3.3e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—IL6—atopic dermatitis	2.22e-06	3.3e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—IL6—atopic dermatitis	2.02e-06	3e-05	CbGpPWpGaD
